ID

33558

Descripción

Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02135757

Link

https://clinicaltrials.gov/show/NCT02135757

Palabras clave

Versiones (1)
  1. 13/12/18 13/12/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

13 de diciembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Colorectal Cancer Metastatic NCT02135757

Inglés

Eligibility Colorectal Cancer Metastatic NCT02135757

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with a histologically confirmed diagnosis of mcrc.
Descripción

Secondary malignant neoplasm of large intestine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0346973
immunohistochemical evidence of egfr expression.
Descripción

Epidermal Growth Factor Receptor Expression Immunohistochemistry

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0034802
UMLS CUI [1,2]
C0597360
UMLS CUI [1,3]
C0021044
ecog performance status of 0, 1 or 2.
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
patients refractory to fluoropyrimidine, oxaliplatin, and irinotecan chemotherapy regimens
Descripción

Chemotherapy refractory | fluoropyrimidine | oxaliplatin | irinotecan

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205269
UMLS CUI [2]
C0596581
UMLS CUI [3]
C0069717
UMLS CUI [4]
C0123931
patients with a wt kras scheduled to receive panitumumab as a single agent for the third-line treatment of mcrc or patients with a mt kras scheduled to receive soc for third-line treatment of mcrc.
Descripción

Patients KRAS wt Allele | panitumumab | Third line treatment Secondary malignant neoplasm of large intestine | Patients KRAS gene Mutated | Standard of Care Third line treatment Secondary malignant neoplasm of large intestine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1705982
UMLS CUI [2]
C0879427
UMLS CUI [3,1]
C2986605
UMLS CUI [3,2]
C0346973
UMLS CUI [4,1]
C0030705
UMLS CUI [4,2]
C1537502
UMLS CUI [4,3]
C1705285
UMLS CUI [5,1]
C2936643
UMLS CUI [5,2]
C2986605
UMLS CUI [5,3]
C0346973
signed and dated irb-approved informed consent document.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
ability to read and understand english or french.
Descripción

Able to read English Language | Able to read French language | Comprehension English Language | Comprehension French language

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0586740
UMLS CUI [1,2]
C0376245
UMLS CUI [2,1]
C0586740
UMLS CUI [2,2]
C0376246
UMLS CUI [3,1]
C0233733
UMLS CUI [3,2]
C0376245
UMLS CUI [4,1]
C0233733
UMLS CUI [4,2]
C0376246
18 years of age or older.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
acquired immunodeficiency syndrome (aids-related illnesses) or known hiv disease.
Descripción

Acquired Immunodeficiency Syndrome | Illness AIDS Related

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001175
UMLS CUI [2,1]
C0221423
UMLS CUI [2,2]
C0001175
UMLS CUI [2,3]
C0439849
Volver a la parte superior de la página

Similar models

Eligibility Colorectal Cancer Metastatic NCT02135757

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Secondary malignant neoplasm of large intestine
Item
patients with a histologically confirmed diagnosis of mcrc.
boolean
C0346973 (UMLS CUI [1])
Epidermal Growth Factor Receptor Expression Immunohistochemistry
Item
immunohistochemical evidence of egfr expression.
boolean
C0034802 (UMLS CUI [1,1])
C0597360 (UMLS CUI [1,2])
C0021044 (UMLS CUI [1,3])
ECOG performance status
Item
ecog performance status of 0, 1 or 2.
boolean
C1520224 (UMLS CUI [1])
Chemotherapy refractory | fluoropyrimidine | oxaliplatin | irinotecan
Item
patients refractory to fluoropyrimidine, oxaliplatin, and irinotecan chemotherapy regimens
boolean
C0392920 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
C0596581 (UMLS CUI [2])
C0069717 (UMLS CUI [3])
C0123931 (UMLS CUI [4])
Patients KRAS wt Allele | panitumumab | Third line treatment Secondary malignant neoplasm of large intestine | Patients KRAS gene Mutated | Standard of Care Third line treatment Secondary malignant neoplasm of large intestine
Item
patients with a wt kras scheduled to receive panitumumab as a single agent for the third-line treatment of mcrc or patients with a mt kras scheduled to receive soc for third-line treatment of mcrc.
boolean
C0030705 (UMLS CUI [1,1])
C1705982 (UMLS CUI [1,2])
C0879427 (UMLS CUI [2])
C2986605 (UMLS CUI [3,1])
C0346973 (UMLS CUI [3,2])
C0030705 (UMLS CUI [4,1])
C1537502 (UMLS CUI [4,2])
C1705285 (UMLS CUI [4,3])
C2936643 (UMLS CUI [5,1])
C2986605 (UMLS CUI [5,2])
C0346973 (UMLS CUI [5,3])
Informed Consent
Item
signed and dated irb-approved informed consent document.
boolean
C0021430 (UMLS CUI [1])
Able to read English Language | Able to read French language | Comprehension English Language | Comprehension French language
Item
ability to read and understand english or french.
boolean
C0586740 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0586740 (UMLS CUI [2,1])
C0376246 (UMLS CUI [2,2])
C0233733 (UMLS CUI [3,1])
C0376245 (UMLS CUI [3,2])
C0233733 (UMLS CUI [4,1])
C0376246 (UMLS CUI [4,2])
Age
Item
18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Acquired Immunodeficiency Syndrome | Illness AIDS Related
Item
acquired immunodeficiency syndrome (aids-related illnesses) or known hiv disease.
boolean
C0001175 (UMLS CUI [1])
C0221423 (UMLS CUI [2,1])
C0001175 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial